Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

3.70
Delayed Data
As of Jul 26
 +0.01 / +0.27%
Today’s Change
2.38
Today|||52-Week Range
6.23
-12.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues12.3M16.2M35.4M43.0M
 
 
 
 
 
Cost of Goods Sold6.1M5.7M5.3M5.4M
 
 
 
 
 
Depreciation And Amortization926.0K473.0K386.0K419.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.3M10.0M29.8M37.2M
 
 
 
 
 
General Expenses27.0M28.4M51.3M57.2M
 
 
 
 
 
Research And Development18.6M21.0M41.4M48.8M
 
 
 
 
 
Total Operating Expenses34.0M34.6M57.0M63.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.6M-18.4M-21.5M-20.0M
 
 
 
 
 
Interest Expense On Debt2.6M2.7M2.7M2.7M
 
 
 
 
 
Other Expenses11.5M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.7M-21.0M-24.2M-22.7M
 
 
 
 
 
Net Income-12.7M-21.0M-24.2M-22.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS141.4M142.2M142.8M143.3M
 
 
 
 
 
Shares To Calculate EPS Diluted141.4M142.2M142.8M143.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.15-$0.17-$0.16
 
 
 
 
 
EPS Diluted-$0.09-$0.15-$0.17-$0.16